Edition:
United Kingdom

CRH Medical Corp (CRH.TO)

CRH.TO on Toronto Stock Exchange

3.80CAD
18 Apr 2019
Change (% chg)

$0.04 (+1.06%)
Prev Close
$3.76
Open
$3.76
Day's High
$3.80
Day's Low
$3.67
Volume
79,148
Avg. Vol
141,675
52-wk High
$5.91
52-wk Low
$3.37

Summary

Name Age Since Current Position

Anthony Holler

63 2005 Independent Chairman of the Board

Tushar Ramani

55 2019 Chief Executive Officer

Richard Bear

48 2006 Chief Financial Officer

Jay Kreger

2016 President of CRH Anesthesia Management

David Johnson

2010 Independent Director

Bergein Overholt

2009 Independent Director

Todd Patrick

49 2006 Independent Director

Ian Webb

61 2006 Independent Director

Adam Peeler

IR Contact Officer

Biographies

Name Description

Anthony Holler

Dr. Anthony F. Holler, M.D., is Independent Chairman of the Board of CRH Medical Corporation, since December 21, 2005. Dr. Holler was appointed as a director of the Company on December 21, 2005. Dr. Holler is one of the founders of ID Biomedical Corporation and held a number of executive positions with ID Biomedical including Chief Executive Officer and Director. Dr. Holler resigned from ID Biomedical upon the completion of ID Biomedical's acquisition by GlaxoSmithKline. Prior to founding ID Biomedical, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia.

Tushar Ramani

Dr. Tushar Ramani is Chief Executive Officer, Director of the Company. He was a co-founder and president of Anesthetix Management, LLC, a national provider of comprehensive anesthesiology and pain management solutions to hospitals and surgery centers, which was acquired by TeamHealth Holdings, Inc., a physician services organization listed on the NYSE at that time. From 2009 to 2012, Dr. Ramani remained as President of TeamHealth's Anesthesia Division, growing it to over $300 million in revenue. More recently, in 2016, Dr. Ramani joined Summit Partners’ Executive-in-Residence program, working with Summit’s Healthcare & Life Sciences team to identify new investment opportunities within growth-stage healthcare companies, as well as to evaluate prospects of current investments. In connection with that appointment, he was named Chief Executive Officer of portfolio company, MedOptions, Inc., the nation's largest behavioral health services provider to post-acute care facilities, in 2018 and served in that capacity until April 2019.

Richard Bear

Mr. Richard K. Bear is Chief Financial Officer of CRH Medical Corporation since March 22, 2006. Mr. Bear was the Chief Financial Officer of ID Biomedical Corporation from June 2005 until GlaxoSmithKline acquired the company in December 2005. He served as Vice President, Finance of ID Biomedical from June 2002 through May 2005. Prior to joining ID Biomedical, Mr. Bear was with XO Communications from September 1995 until May 2002, where he held the positions of Vice President/General Manager and Vice President of Finance. Mr. Bear received his degree in Business Administration from the University of Washington and is a Certified Public Accountant (CPA).

Jay Kreger

Mr. Jay Kreger is President of CRH Anesthesia Management of the Company. He has been working in the healthcare field since 2005 and was most recently with Medical Care America, a division of Hospital Corporation of America. While at Medical Care America, Jay was involved in helping grow a network of over 130 ambulatory surgery centers, including endoscopy centers, through both acquisition and physician partnership models. Jay was deal lead on a significant number of transactions that contributed to the growth of HCA's ambulatory surgery division. Jay also brings with him significant operations and finance expertise.

David Johnson

Dr. David Johnson is Independent Director of CRH Medical Corporation, since June 1, 2010. Dr. Johnson has been a partner of Gastrointestinal and Liver Specialists of Tidewater, PLLC in Norfolk, VA since 1989, having served at the National Naval Medical Center Gastroenterology division from 1984 to 1989. Dr. Johnson also serves as Professor of Medicine, Chief of Gastroenterology, Eastern Virginia Medical School and is Board-certified in Internal Medicine and Gastroenterology. Additionally, he is a past President of American College of Gastroenterology.

Bergein Overholt

Dr. Bergein F. Overholt, M.D., is Independent Director of CRH Medical Corporation, since September 24, 2009. Dr. Overholt is Managing Director of Gastrointestinal Associates in Knoxville, TN. He is a past President of the American Society for Gastrointestinal Endoscopy and the American Association of Ambulatory Surgery Centers.

Todd Patrick

Mr. Todd R. Patrick is Independent Director of CRH Medical Corporation since May 25, 2006. Since November 2010, Mr. Patrick has been the President and CEO of C3 Jian, Inc. a private biotechnology company based in Los Angeles, CA. Prior to joining C3 Jian, Mr. Patrick was employed by ID Biomedical Corporation as its President from July 1994 to January 2006, when he resigned upon the completion of ID Biomedical's acquisition by GlaxoSmithKline.

Ian Webb

Mr. Ian A. Webb is Independent Director of CRH Medical Corporation since May 25, 2006. Mr. Webb has been retired since December 31, 2010. Prior to that, he was a partner of the law firm of Borden Ladner Gervais LLP. His practice focused on corporate and securities law with an emphasis on the legal requirements of public companies.

Adam Peeler

Basic Compensation